medigraphic.com

2020, Number 3

Next >>

Revista Cubana de Angiología y Cirugía Vascular 2020; 21 (3)

Asymptomatic peripheral arterial disease in people with type 2 diabetes

García GY, Guerra FL, Domínguez AE, González HO, Acosta CA, Conesa GAI

Language: Spanish
References: 30
Page: 1-19
PDF size: 489.90 Kb.


ABSTRACT

Introduction: Peripheral arterial disease is a frequent and devastating complication in people with diabetes. This condition can appear from prediabetes stages; however, it is not established when to carry out the screening of asymptomatic young adult patients with short time of evolution of the disease.
Objective: To characterize asymptomatic peripheral arterial disease in patients with type 2 diabetes.
Methods: An analytical cross-sectional study was carried out with 190 diabetic patients with type 2 diabetes aged 40-60 years and with less than ten years of evolution of the disease. The selection included, as of September 2017, the patients admitted to the Diabetic Care Center of the Institute of Endocrinology without prior diagnosis of peripheral arterial disease. The diagnosis was done based on the ankle/arm pressure index.
Results: 6.3% (n=12) had asymptomatic peripheral arterial disease. There were no significant differences between the variables studied and the occurrence of asymptomatic peripheral arterial disease, which was significantly related to the presence of ischemic heart disease. Arterial involvement was slight in all the patients identified and was associated with ischemic heart disease; this was not the case with other clinical variables under study. Neither did the combination of these variables increase the risk for the onset of the disease.
Conclusions: Asymptomatic peripheral arterial disease is a rare complication in diabetic people under 60 years of age and with less than ten years of evolution of the disease.


REFERENCES

  1. International Diabetes Federation (IDF). The global pictures. The IDF Diabetes Atlas. 9 Ed. IDF; 2019. p. 50-7 [acceso 03/01/2020]. Disponible en: https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf

  2. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico 2018. La Habana; 2019 [acceso 03/01/2020]. Disponible en: https://files.sld.cu/bvscuba/files/2019/04/Anuario-Electrónico-Español-2018-ed-2019 compressed.pdf

  3. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017 [acceso 27/01/2020];376:1407-18. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa1608664

  4. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015 [acceso 27/01/2020];116:1509-26. Disponible en: https://www.ahajournals.org/doi/full/10.1161/circresaha.116.303849

  5. Gibbons GW, Shaw PM. Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient. Semin Vasc Surg. 2012 [acceso 27/01/2020];25:89-92. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0895796712000154

  6. Marone EM, Cozzolino P, Ciampichini R, Chiodini V, Ferraresi R, Rinaldi LF, et al. Peripheral arterial disease in diabetic patients: a long-term population-based study on occurrence, outcomes and cost. J Cardiovasc Surg (Torino). 2018 [acceso 27/01/2020];59(4):572-9. Disponible en: https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=R37Y2018N04A0572

  7. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003 [acceso 27/01/2020];26:3333-41. Disponible en: https://care.diabetesjournals.org/content/26/12/3333

  8. Rivero FE, Escalante O, Rivero T, Morales N, Lazo I. Rol de los factores de riesgo mayores en la macroangiopatía diabética de miembros inferiores. Rev Cubana Angiol y Cir Vasc. 2002 [acceso 22/10/2019];3:24-9. Disponible en: https://bvs.sld.cu/revistas/ang/vol3_2_02/ang04202.htm

  9. Llanes JA, Fernández JI, Seuc AH, Chirino N, Hernández MJ. Caracterización del pie diabético y algunos de sus factores de riesgo. Rev Cubana Angiol y Cir Vasc. 2010 [acceso 22/10/2019];11(1). Disponible en: https://bvs.sld.cu/revistas/ang/vol11_01_10/ang02110.htm

  10. Valdés ER, Espinosa Y. Factores de riesgo asociado con la aparición de enfermedad arterial periférica en personas con diabetes mellitus tipo 2. Rev Cubana Med. 2013 [acceso 22/10/2019];52(1):4-13. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003475232013000100002&lng=es&nrm=iso&tlng=es

  11. Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol. 2016 [acceso 27/01/2020];15:129-32. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010714/

  12. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009 [acceso 27/01/2020];120:2053-61. Disponible en: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.109.865600?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

  13. Wilcox T, Newman JD, Maldonado TS, Rockman C, Berger JS. Peripheral vascular disease risk in diabetic individuals without coronary heart disease. Atherosclerosis. 2018 [acceso 27/01/2020];275:419-25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276116/

  14. Nirala N, Periyasamy R, Kumar A. Noninvasive diagnostic methods for better screening of peripheral arterial disease. Ann Vasc Surg. 2018;52:263-72. DOI: https://doi.org/10.1016/j.avsg.2018.03.018

  15. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 [acceso 27/01/2020];135(12):e726-e79. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477786/

  16. Aboyans V, Ricco JB, Bartelink MEL. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS), the European Stroke Organization (ESO). Eur Heart J. 2018 [acceso 27/01/2020];39.2017:763-816. Disponible en: https://academic.oup.com/eurheartj/article/39/9/763/4095038

  17. Ato D. Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity. Vasc Health Risk Manag. 2018 [acceso 27/01/2020];14:41-62. Disponible en: https://www.dovepress.com/pitfalls-in-the-ankle-brachial-index-and-brachial-ankle-pulse-wave-vel-peer-reviewed-fulltext-article-VHRM

  18. American Diabetes Association.11. Microvascular complications and foot care: Standards of medical care in diabetes 2020. Diabetes Care. 2020 [acceso 27/01/2020];43(Suppl. 1):S131-S51. Disponible en: https://care.diabetesjournals.org/content/43/Supplement_1/S135.long

  19. World Health Organization. Consultation on obesity. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894, Genova; 2000 [acceso 27/01/2020]. Disponible en: https://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/

  20. Fowkes FG, Rudan D, Rudan I. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. DOI: https://doi.org/10.1016/S0140-6736(13)61249-0

  21. Rhee SY, Guan H, Liu ZM. Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res Clin Pract. 2007 [acceso 27/01/2020];76:82-92. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0168822706003470.pdf?locale=es_ES&searchIndex=

  22. Roca MM, Carral F, Baena G, Sánchez Z, Valencia I, Aguilar M. Evaluación de la enfermedad vascular periférica en pacientes con diabetes tipo 2 mediante medición del índice tobillo-brazo. Avd Diabetol. 2007 [acceso 27/01/2020];23:370-4. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/ibc-058632

  23. Jelani Q, Petrov M, Martinez SC, Holmvang L, Al-Shaibi K, Alasnag M. Peripheral arterial disease in women: an overview of risk factor profile, clinical features, and outcomes. Current Atherosclerosis Reports. 2018 [acceso 27/01/2020];20:40-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984648/

  24. Singh S, Bailey KR, Kullo IJ. Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease. Int J Cardiol. 2013 [acceso 27/01/2020];162:228-33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174274/

  25. Fortes-Lima C, Bybjerg-Grauholm J, Marin-Padrón LC, Gomez-Cabezas EJ, Bækvad-Hansen M, Søholm Hansen C, et al. Exploring Cuba’s population structure and demographic history using genome wide data. Scientific reports. 2018;11422. DOI: https://doi.org/10.1038/s41598-018-29851-3

  26. Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean Cohort. Angiology. 2008 [acceso 27/01/2020];58:689-97. Disponible en: https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=18216378&lang=es&site=ehost-live

  27. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ. et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992 [acceso 27/01/2020];135:331-40. Disponible en: https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=1550087&lang=es&site=ehost-live

  28. Emdin CA, Anderson SG, Callender T, Conrad N, Salimi-Khorshidi G, Mohseni H, et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4,2 million adults. BMJ. 2015 [acceso 27/01/2020];351:h4865. Disponible en: https://www.bmj.com/content/351/bmj.h4865

  29. Tobias DK. Addressing reverse causation bias in the obesity paradox is not “one size fits all”. Diabetes Care. 2017 [acceso 27/01/2020];40(8):1000-1. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521974/

  30. García García Y, Díaz Batista A, Arpajón Peña Y, Aldama Figueroa A, Conesa González AI, del Busto Mesa A. Enfermedad arterial periférica asintomática en pacientes con factores de riesgo del síndrome metabólico. Rev Cubana Angiol y Cir Vasc. 2018 [acceso 27/01/2020];19(2). Disponible en: https://revangiologia.sld.cu/index.php/ang/article/view/9/6




2020     |     www.medigraphic.com